Landscapes / Companies
Puma Biotechnology, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
3 active
8 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Oct 2027Phase 2 trial completes | |||
| Next date | 30 Oct 2027 · Phase 2 trial completes | ||||
| Also tested for | Small Cell Lung Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer and 3 more | ||||
| Open drug page | |||||
About
- No active trial
- neratinib
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021